2020 American Transplant Congress Archives - Page 46 of 223

ATC Virtual Congress
Live Broadcast Dates: May 30 - June 1, 2020
OnDemand Access: May 30, 2020 - June 4, 2021

Originally scheduled to take place in Philadelphia, this became a Virtual Congress due to COVID-19. For more information, visit The Official ATC Congress site.

Saturday, May 30, 2020

3:30pm-4:00pm: Clinical Study of Standard versus Reduced Dose Tacrolimus Combined with Generic Mycophenolate Mofetil in De Novo Kidney Transplantation

J. Bang, C. Oh

Poster Session C: Kidney Immunosuppression: Novel Regimens and Drug Minimization • Virtual

3:30pm-4:00pm: Clinicopathologic Features and Risk Factors of Proteinuria in Transplant Glomerulopathy: A Cross-Sectional Study

Q. Zhang¹, K. Budde¹, D. Schmidt¹, F. Halleck¹, M. Dürr¹, M. Naik¹, M. Mayrdorfer¹, W. Düttmann-Rehnolt¹, F. Klauschen², B. Rudolph², K. Wu²

Poster Session C: Kidney Complications: Immune Mediated Late Graft Failure • Virtual

3:30pm-4:00pm: Clinicopathological Evaluation of Long-Term Survivor More Than 10 Years after Living Kidney Transplant with Corticosteroid Early Withdrawal Protocol

H. Sasaki¹, T. Tanabe¹, H. Higuchi¹, T. Tsujimoto², H. Harada¹

Poster Session A: Kidney Immunosuppression: Induction Therapy • Virtual

3:30pm-4:00pm: Cmv Infection Sensitizes Transplant Recipients by Promoting Alloreactive T Cell Response

S. Yu, A. Dangi, X. Luo

Poster Session D: Tolerance / Immune Deviation • Virtual

3:30pm-4:00pm: CMV, EBV and BKV Viremia Rate Varied Depending on the Timing of Conversion to Belatacept (BLT)- from Calcineurin Inhibitor (CNI)-Based Immunosuppression and HLA-Sensitization (HS) Status in Kidney Transplant Patients (KTx Pts)

B. Shin, N. Ammerman, A. Vo, S. C. Jordan, M. Toyoda, S. Sethi

Poster Session D: Kidney Immunosuppression: Novel Regimens and Drug Minimization • Virtual

3:30pm-4:00pm: Cognitive Impairment is Highly Prevalent in Lung Transplant Candidates

A. O'Boye, K. Leitner, M. Kelly, J. Wright, L. Pesce, M. Sala, R. Tomic

Poster Session C: Lung: All Topics • Virtual

3:30pm-4:00pm: Combined Heart-Liver Transplantation Has Excellent Long-Term Outcomes

J. A. Steadman¹, J. M. Stulak¹, A. L. Clavell², S. S. Kushwaha², B. S. Edwards², N. L. Pereira², B. A. Boilson², A. Behfar², R. J. Rodeheffer², J. A. Dearani¹, T. Taner³, R. C. Daly¹

Poster Session B: Heart and VADs: All Topics • Virtual

3:30pm-4:00pm: Combined Heart-Liver Transplantation: A Systematic Review of the Literature

I. A. Ziogas¹, D. Giannis², P. Kapsampelis², A. Giannopoulou², A. Evangeliou², K. S. Mylonas², G. Tsoulfas³, L. K. Matsuoka¹, M. I. Montenovo¹, M. Izzy¹, S. P. Alexopoulos¹

Poster Session C: Heart and VADs: All Topics • Virtual

3:30pm-4:00pm: Combined Phenotyping to Identify Kidney Transplants at Greatest Risk after Subclinical Acute Rejection

S. Park¹, R. Heilman², E. Poggio³, D. Taber⁴, L. Zhao¹, K. Guo¹, S. Kurian⁵, C. Rebello¹, S. Brietigam¹, M. Abecassis⁶, J. Friedewald¹

Poster Session A: Biomarkers, Immune Assessment and Clinical Outcomes • Virtual

3:30pm-4:00pm: Combining New Biomarkers: Donor Derived Cell Free DNA (dd-cfDNA) and Transcriptomics Impacts Rejection Diagnosis, Treatment and Follow Up

S. Anand, L. Dong, D. Miller, I. Lloyd, D. Morris, T. Srinivas

Poster Session C: Biomarkers, Immune Assessment and Clinical Outcomes • Virtual